BT524 · Hematology BT524 is a human monoclonal antibody that binds to and neutralizes tissue factor pathway inhibitor (TFPI) to enhance thrombin generation and hemostasis.
BT524 (Part I) · Hematology BT524 is a human monoclonal antibody that binds to and neutralizes tissue factor pathway inhibitor (TFPI) to enhance thrombin generation and hemostasis.
BT524 (Part II) · Hematology BT524 is a human monoclonal antibody that binds to and neutralizes tissue factor pathway inhibitor (TFPI) to enhance thrombin generation and hemostasis.
BT595 · Hematology BT595 is a human monoclonal antibody that binds to and neutralizes tissue factor pathway inhibitor (TFPI) to enhance thrombin generation and hemostasis.
FFP/Cryo · Hematology / Critical Care FFP/Cryo is a combination blood product therapy that replaces clotting factors and fibrinogen to restore hemostatic function in patients with severe bleeding or coagulopathy.
IgG Next Generation (BT595) · Immunology BT595 is a next-generation intravenous immunoglobulin (IVIG) product designed to provide passive immunity through polyclonal IgG antibodies with enhanced manufacturing and purification processes.
Placebo (human albumin 1%) · Critical Care / Hematology Human albumin 1% serves as a volume expander and oncotic agent to maintain intravascular fluid balance and plasma colloid osmotic pressure.